Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Andrew Pettitt

Personal Chair

University of Liverpool

United Kingdom

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in United Kingdom Professors in Epidemiology Epidemiology professors in United Kingdom

Articles (20)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Collaborators (12)

Francesco Forconi

Professor of Haematology

University of Southampton

UNITED KINGDOM

View details

Natasha Greatorex

Head of Clinical Trial Management

University of Leeds

UNITED KINGDOM

View details

Yeong Jer Lim

University of Liverpool

UNITED KINGDOM

View details

Rachael Cooper

Trial Statistician

University of Liverpool

UNITED KINGDOM

View details

David Allsup

Professor

Hull York Medical School

UNITED KINGDOM

View details

Helen Parry

Senior Clinical Lecturer/Associate Professor

University of Birmingham

UNITED KINGDOM

View details

Catrin Tudur Smith

Personal Chair

University of Liverpool

UNITED KINGDOM

View details

Joseph Slupsky

Personal Chair

University of Liverpool

UNITED KINGDOM

View details

Adrian Bloor

MAHSC Honorary Clinical Professor

University of Manchester

UNITED KINGDOM

View details

Dean Bryant

Associate Professor of Computational Cancer Biology

University of Southampton

UNITED KINGDOM

View details

John C. Riches

Consultant Haemato-oncologist, Barts Health NHS Trust, Clinical Reader in Cancer Immunometabolism, Barts Cancer Institute

Barts Health NHS Trust

UNITED KINGDOM

View details

Professor Jonathan C Strefford

Professor of Molecular Oncology

University of Southampton

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Andrew Pettitt

Research Interests

Make your next move.

Explore related searches

Articles (20)

Trends and socio‐economic disparities in chronic lymphocytic leukaemia 2014–2022: An England‐wide cohort study from the UNCOVER group

High-risk molecular features may eclipse genomic complexity in predicting chronic lymphocytic leukemia outcomes; UK clinical trial insights

Coronavirus disease 2019 (COVID‐19) risk and evolving treatment patterns in follicular lymphoma during the pandemic: Insights from the PETReA trial

Effect of age and sex on cardiovascular outcomes among patients with chronic lymphocytic leukemia treated with Bruton tyrosine kinase inhibitors: a propensity matched analysis

Lenalidomide-rituximab or lenalidomide-rituximab-bendamustine for relapsed/refractory follicular lymphoma: primary and final analysis of the randomized phase II HOVON110/ReBeL study.

Measurable Residual Disease-Guided Therapy for Chronic Lymphocytic Leukemia.

Real world epidemiological trends in nodular lymphocyte predominant Hodgkin lymphoma (NLPHL), England 2014-2021: Preliminary data from the uncover Study group

Respiratory syncytial virus (RSV) infection in adults with blood cancer: An England-wide population study

The impact of frailty on real world outcomes for multiple myeloma patients in England - a cohort study from the uncover study group and ukmra frailty group.

Treatment intensity and region of diagnosis affect survival in primary CNS lymphoma in England: A national cohort study from the uncover project

Re-emergence of circulating non-malignant B cells as a prognostic biomarker in chronic lymphocytic leukaemia

PA-382 Frailty and Social Deprivation Affect Real-World Outcomes in Multiple Myeloma (MM) – an England-Wide Cohort Study from the UNCOVER Study Group and UKMRA Frailty Group

331 | INCIDENCE AND SURVIVAL OF PRIMARY CNS LYMPHOMA: AN ENGLAND‐WIDE COHORT STUDY FROM THE UNCOVER STUDY GROUP

481 | ADAPTIVE RESISTANCE IN LYMPHOPROLIFERATIVE DISORDERS: POTENTIAL ROLES OF SNHG32, A NOVEL NON‐CODING TUMOUR SUPPRESSOR

2025 British Society for Haematology Guideline for the treatment of chronic lymphocytic leukaemia

617 | INCIDENCE AND SURVIVAL OF MANTLE CELL LYMPHOMA IN ENGLAND 2014–2021: A NATIONAL COHORT STUDY FROM THE UNCOVER STUDY GROUP

Analysis of the role of baseline PET/CT in a prospective study of unselected patients: The UK MCL biobank

The unfolded protein response influences therapy outcome and disease progression in chronic lymphocytic leukaemia

96 | FOLLICULAR LYMPHOMA EPIDEMIOLOGY AND OUTCOMES IN ENGLAND 2014–2021: PRELIMINARY ANALYSIS FROM THE UNCOVER STUDY GROUP

98 | FLUDARABINE, CYCLOPHOSPHAMIDE AND RITUXIMAB (FCR) AS INITIAL TREATMENT FOR HIGH TUMOUR BURDEN FOLLICULAR LYMPHOMA: FINAL RESULTS OF THE UK PHASE III PACIFICO TRIAL

Collaborators (12)

Francesco Forconi

Natasha Greatorex

Yeong Jer Lim

Rachael Cooper

David Allsup

Helen Parry

Catrin Tudur Smith

Joseph Slupsky

Adrian Bloor

Dean Bryant

John C. Riches

Professor Jonathan C Strefford

Make your next move.